Double Delight For Novartis At The CHMP

Backing For MS Drug Mayzent And Isturisa For Cushing's

 
• By Kevin Grogan
  
Hurdles
Mayzent Over Final Hurdle Before European approval • Source: Shutterstock

More from New Products

More from Scrip